Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
The Tumor Stroma of Squamous Cell Carcinoma: A Complex Environment That Fuels Cancer Progression
Alexandra Buruiană, Bogdan‐Alexandru Gheban, Ioana‐Andreea Gheban‐Roșca, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1727-1727
Open Access | Times Cited: 7
Unraveling the secrets: Evolution of resistance mediated by membrane proteins
Xue Yang, Min Li, Zi-Chang Jia, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101140-101140
Open Access | Times Cited: 6
HSF1 at the crossroads of chemoresistance: from current insights to future horizons in cell death mechanisms
Shruti Ghai, Rejina Shrestha, Kuo‐Hui Su
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Genomische Instabilität als Rationale bei der Krebstherapie
Anna Fichtl, Thomas Jens Ettrich, Lukas Perkhofer
Forum (2025)
Closed Access
Manzamine A: A Promising Marine-Derived Cancer Therapeutic for Multi-targeted Interactions with E2F8, SIX1, AR, GSK-3β, and V-ATPase - A Systematic Review
Mohammad Amir Mishan, Yeun‐Mun Choo, Jeffery Winkler, et al.
European Journal of Pharmacology (2025), pp. 177295-177295
Open Access
Carbon Nanodots as a Red Emissive Fluorescent Probe for the Super‐Resolution Microscopy of DNA Dynamics during Paclitaxel Treatment
Richa Garg, Kush Kaushik, Abdul Salam, et al.
Small Structures (2025)
Open Access
Advanced Biomarkers and Precision Medicine: Innovative Strategies to Prevent Cancer Recurrence
MS Ganesh, R. Revanth, C. Mahesh Elaya Bharathi
Journal of cancer research updates (2025) Vol. 14, pp. 1-11
Closed Access
Roles of anoikis in hepatocellular carcinoma: mechanisms and therapeutic potential
Chen Chen, Mengyao Wang, Daoyuan Tu, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
The anti-cancer activity of Dioscin: an update and future perspective
M Y Wang, Yanan Zhang, SongLin Ni, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Open Access
Autophagy induced by metabolic processes leads to solid tumor cell metastatic dormancy and recurrence
Saeid Ferdousmakan, Dorrin Mansourian, Fatemeh Sadat Seyedi Asl, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
Pharmacogenomics influence on MDR1-associated cancer resistance and innovative drug delivery approaches: advancing precision oncology
Arun Radhakrishnan, Nikhitha K Shanmukhan, Samuel Lihan
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
Novel Aryl Substituted sulfonyl piperazine derivatives: Tandem one-pot multi component synthesis via palladium catalyzed Suzuki-Miyaura cross coupling, structure studies and evaluation of anticancer activity
A. S. Jeevan Chakravarthy, A Shriraksha, N.R. Sreenatha, et al.
Research Square (Research Square) (2025)
Closed Access
Mass Spectrometry‐Based Proteomics Technologies to Define Endogenous Protein‐Protein Interactions and Their Applications to Cancer and Viral Infectious Diseases
Clinton Yu, Rithika Adavikolanu, Robyn M. Kaake, et al.
Mass Spectrometry Reviews (2025)
Closed Access
HYPOXIA INDUCED MITOPHAGY GENERATES REVERSIBLE METABOLIC AND REDOX HETEROGENEITY WITH TRANSIENT CELL DEATH SWITCH DRIVING TUMORIGENESIS
Shivanshu Kumar Tiwari, Aneesh Chandrasekharan, Santhik Subhasingh Lupitha, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Quinalizarin induces autophagy, apoptosis and mitotic catastrophe in cervical and prostate cancer cells
Wojciech Trybus, Ewa Trybus, Mateusz Obarzanowski, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
lncRNAs: New players of cancer drug resistance via targeting ABC transporters
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 5
Molecular Mechanisms of Drug Resistance in Leishmania spp.
María Juliana Moncada-Díaz, Cristian Camilo Rodríguez-Almonacid, Eyson Quiceno-Giraldo, et al.
Pathogens (2024) Vol. 13, Iss. 10, pp. 835-835
Open Access | Times Cited: 5
A Review of the Efficacy of Nanomaterial-Based Natural Photosensitizers to Overcome Multidrug Resistance in Cancer
Jagadeesh Rajaram, Lokesh Kumar Mende, Yaswanth Kuthati
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1120-1120
Open Access | Times Cited: 4
Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities—A State-of-the-Art Review
Dominika Kunachowicz, Karolina Kłosowska, N. Sobczak, et al.
Nanomaterials (2024) Vol. 14, Iss. 17, pp. 1424-1424
Open Access | Times Cited: 3
The Therapeutic Potential of Bee Venom-Derived Apamin and Mellitin Conjugates in Cancer Treatment: A Systematic Review
Lucas Fornari Laurindo, Enzo Pereira de Lima, Lívia Fornari Laurindo, et al.
Pharmacological Research (2024), pp. 107430-107430
Open Access | Times Cited: 3
Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma
Kankamol Kerdkumthong, Sittiruk Roytrakul, Kawinnath Songsurin, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 969-969
Open Access | Times Cited: 2
Autophagy regulates apoptosis of colorectal cancer cells based on signaling pathways
Yuwei Yan, Wenyan Yu, Min Guo, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Fantastic Frogs and Where to Use Them: Unveiling the Hidden Cinobufagin’s Promise in Combating Lung Cancer Development and Progression Through a Systematic Review of Preclinical Evidence
Sandra Maria Barbalho, Karina Torres Pomini, Enzo Pereira de Lima, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3758-3758
Open Access | Times Cited: 2
Introduction to Drug Resistance in Cancer
Shariqa Jan, Kaneez Fatima, Fayaz Malik, et al.
(2024), pp. 1-30
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top